Pharmaceutical behemoth Pfizer has developed an RSV vaccine that is administered to expectant mothers to confer antibody protection from severe disease to their unborn babies through six months of age. The Daily Mail
See also:
This blog covers the latest UK health care news, publications, policy announcements, events and information focused on the NHS, as well as the latest media stories and local news coverage of the NHS Trusts in Northamptonshire.
No comments:
Post a Comment